Literature DB >> 10592092

Hypoglycaemia and the neonatal brain.

J M Hawdon1.   

Abstract

UNLABELLED: There has been much controversy and confusion regarding potential damage caused to the neonatal brain by low blood glucose levels. Previous studies of outcome after neonatal hypoglycaemia are flawed by many factors including retrospective data collection and inability to control for co-existing clinical complications. There is no doubt that hypoglycaemic brain damage does occur but the severity and duration of low blood glucose levels required to cause lasting harm varies between subjects and is related to the ability of each baby to mount a protective response such as the production of ketone bodies which are alternative cerebral fuels. Evidence from studies of humans and other animals suggests that cortical damage and long-term sequelae occur after prolonged hypoglycaemia sufficiently severe to cause neurological signs.
CONCLUSION: Prolonged hypoglycaemia should be avoided by close clinical observation of vulnerable infants whilst avoiding excessively invasive management in populations of neonates which may jeopardize the successful establishment of breast feeding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592092     DOI: 10.1007/pl00014319

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation.

Authors:  David G Cotter; Rebecca C Schugar; Anna E Wentz; D André d'Avignon; Peter A Crawford
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-11       Impact factor: 4.310

2.  Assessment of the Institute of Medicine recommendations for weight gain during pregnancy: Florida, 2004-2007.

Authors:  Sohyun Park; William M Sappenfield; Connie Bish; Hamisu Salihu; David Goodman; Diana M Bensyl
Journal:  Matern Child Health J       Date:  2011-04

3.  Enhanced [3H] glutamate binding in the cerebellum of insulin-induced hypoglycaemic and streptozotocin-induced diabetic rats.

Authors:  Anu Joseph; Remya Robinson; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2007-09-06       Impact factor: 5.046

Review 4.  What's new in metabolic and genetic hypoglycaemias: diagnosis and management.

Authors:  Vassili Valayannopoulos; Stéphane Romano; Karine Mention; Anne Vassault; Daniel Rabier; Michel Polak; Jean-Jacques Robert; Yves de Keyzer; Pascale de Lonlay
Journal:  Eur J Pediatr       Date:  2007-10-03       Impact factor: 3.183

5.  Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats.

Authors:  Remya Robinson; Amee Krishnakumar; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2009-01-09       Impact factor: 5.046

Review 6.  Ketone body metabolism and cardiovascular disease.

Authors:  David G Cotter; Rebecca C Schugar; Peter A Crawford
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-08       Impact factor: 4.733

7.  Neuroprotective potential of Bacopa monnieri and Bacoside A against dopamine receptor dysfunction in the cerebral cortex of neonatal hypoglycaemic rats.

Authors:  Roshni Baby Thomas; Shilpa Joy; M S Ajayan; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2013-08-22       Impact factor: 5.046

8.  Cost-Utility Analysis of Prophylactic Dextrose Gel vs Standard Care for Neonatal Hypoglycemia in At-Risk Infants.

Authors:  Matthew J Glasgow; Richard Edlin; Jane E Harding
Journal:  J Pediatr       Date:  2020-07-04       Impact factor: 4.406

9.  Early blood glucose profile and neurodevelopmental outcome at two years in neonatal hypoxic-ischaemic encephalopathy.

Authors:  Montasser Nadeem; Deirdre M Murray; Geraldine B Boylan; Eugene M Dempsey; Cornelius A Ryan
Journal:  BMC Pediatr       Date:  2011-02-04       Impact factor: 2.125

10.  Serum Metabolomic Profiles in Neonatal Mice following Oral Brominated Flame Retardant Exposures to Hexabromocyclododecane (HBCD) Alpha, Gamma, and Commercial Mixture.

Authors:  David T Szabo; Wimal Pathmasiri; Susan Sumner; Linda S Birnbaum
Journal:  Environ Health Perspect       Date:  2016-11-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.